Cargando…
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
INTRODUCTION: Neoadjuvant chemotherapy has become the standard of care for the diverse population of women diagnosed with locally advanced breast cancer. Serum biomarker levels are increasingly being investigated for their ability to predict therapy response and aid in the development of individuali...
Autores principales: | Nolen, Brian M, Marks, Jeffrey R, Ta'san, Shlomo, Rand, Alex, Luong, The Minh, Wang, Yun, Blackwell, Kimberly, Lokshin, Anna E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481492/ https://www.ncbi.nlm.nih.gov/pubmed/18474099 http://dx.doi.org/10.1186/bcr2096 |
Ejemplares similares
-
Do serum biomarkers really measure breast cancer?
por: Jesneck, Jonathan L, et al.
Publicado: (2009) -
Prediagnostic Serum Biomarkers as Early Detection Tools for Pancreatic Cancer in a Large Prospective Cohort Study
por: Nolen, Brian M., et al.
Publicado: (2014) -
Neoadjuvant chemotherapy for locally advanced cervical cancer
por: Iwata, Takashi, et al.
Publicado: (2016) -
Neoadjuvant chemotherapy in locally advanced duodenal adenocarcinoma
por: Velandia, Carlos, et al.
Publicado: (2018) -
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
por: Papaccio, Federica, et al.
Publicado: (2020)